Pharmacokinetics of platinum cytostatics after cisplatin-related equitoxic dosing to rats
Amlacher, R.; Winnefeld, K.; Schröter, H.; Hoffmann, H.
Die Pharmazie 43(11): 798-800
1988
ISSN/ISBN: 0031-7144 PMID: 3247371 Document Number: 316947
Document emailed within 1 workday
Related Documents
Fichtinger-Schepman, A.M.; Vendrik, C.P.; van Dijk-Knijnenburg, W.C.; de Jong, W.H.; van der Minnen, A.C.; Claessen, A.M.; van der Velde-Visser, S.D.; de Groot, G.; Wubs, K.L.; Steerenberg, P.A. 1989: Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma Cancer Research 49(11): 2862-2867Cho, Y.B.; Kim, D.K.; Kim, K.H.; Miyamoto, G. 1996: Pharmacokinetics of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3-dioxolane]platinum(II) in rats Arzneimittel-Forschung 46(6): 629-634
Ota, K.; Oguma, T.; Shimamura, K. 1994: Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S Anticancer Research 14(3b): 1383-1387
Hannemann, J.; Baumann, K. 1988: Inhibition of lactate-dehydrogenase by cisplatin and other platinum-compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitro Research Communications in Chemical Pathology and Pharmacology 60(3): 371-379
Johnson, S.W.; Swiggard, P.A.; Handel, L.M.; Brennan, J.M.; Godwin, A.K.; Ozols, R.F.; Hamilton, T.C. 1994: Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells Cancer Research 54(22): 5911-5916
Wongtawatchai, T.; Agthong, S.; Kaewsema, A.; Chentanez, V. 2009: Sex-related differences in cisplatin-induced neuropathy in rats Journal of the Medical Association of Thailand 92(11): 1485-1491
Hyodo, I. 2006: S-1 combined with weekly dosing of cisplatin for metastatic gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 1): 64-67
Escudero Barrilero, A.; Mateos Torres, A.; Maganto Pavón, E.; Mayayo Dehesa, T.; Allona Almagro, A.; Escribano Patiño, G.; Zubioca Ezpeleta, S.; García González, R. 1985: Intra-arterial administration of cytostatics with obstructed blood flow. Preliminary study in 7 patients with hypernephroma treated with cisplatin Revista Clinica Espanola 176(4): 187-193
Leng, M.; Brabec, V. 1994: DNA adducts of cisplatin, transplatin and platinum-intercalating drugs Iarc Scientific Publications 125: 339-348
Fracasso, M.E.; Apostoli, P.; Benoni, G.; Bonetti, A.; Griso, C.; Leone, R. 1987: Kinetics of platinum in cancer patients treated with cisplatin at different doses Drugs under Experimental and Clinical Research 13(6): 367-372
Berry, J.P.; Brille, P.; LeRoy, A.F.; Gouveia, Y.; Ribaud, P.; Galle, P.; Mathé, G. 1982: Experimental ultrastructural and X-ray microanalysis study of cisplatin in the rat: intracellular localization of platinum Cancer Treatment Reports 66(7): 1529-1533
Shah, J.; Mason, W.D. 1990: Pharmacokinetics of codeine after parenteral and oral dosing in the rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(5): 670-673
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Gorbunova, V.A. 1989: Cisplatin (platidiam) and the prospects for using complex platinum compounds in the clinical chemotherapy of malignant tumors Voprosy Onkologii 35(3): 325-330
Christ, D.D. 2001: Cassette dosing pharmacokinetics: valuable tool or flawed science? Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(7): 935
Edeki, T.; Johnston, A.; Li Kam Wa, E.; Turner, P. 1994: Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing International Journal of Clinical Pharmacology and Therapeutics 32(3): 142-146
Kanthawatana, S.; Uruwannakul, K.; Chotinarumon, S. 1998: Gentamicin pharmacokinetics in Thai neonates: recommendation for a dosing guideline Journal of the Medical Association of Thailand 81(2): 136-140
Mamenta, E.L.; Poma, E.E.; Kaufmann, W.K.; Delmastro, D.A.; Grady, H.L.; Chaney, S.G. 1994: Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines Cancer Research 54(13): 3500-3505
Nemoto, H.; Takeuchi, S.; Yoshizawa, Y.; Uemichi, O.; Sasaya, S.; Yamaguchi, M.; Makuuchi, M.; Midorikawa, T.; Sanada, Y.; Kumada, K.; Takizawa, K. 2001: Tissue platinum distribution and the effect following intra-arterial injection of cisplatin to metastatic liver cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(8): 1149-1153
Bilgi, O.; Karagoz, B.; Alacacioglu, A.; Ozgun, A.; Tuncel, T.; Gokhan-Kandemir, E. 2010: Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 15(2): 395